SecBot SecBot
SECBOTREPLAY Home › Report › JNJ

JNJ · Johnson & Johnson reported Q1 2026 earnings with adjusted EPS of $2.70,…

JOHNSON & JOHNSON · 8-K filed Apr 14, 2026 at 07:35 ET

At the news

BULLISHIMPACT 8/10

8-K filed Apr 14, 2026 at 07:35 ET

Johnson & Johnson reported Q1 2026 earnings with adjusted EPS of $2.70, narrowly beating consensus of $2.68, and raised full-year guidance. The company also announced a 3.1% dividend increase, marking its 64th consecutive annual dividend hike.

  • Adjusted EPS of $2.70 vs. consensus of $2.68
  • Raised full-year 2026 guidance for adjusted EPS to $11.55 at midpoint
  • Declared 3.1% dividend increase to $1.34 per share
  • Innovative Medicine segment grew 11.2% with strong performance in oncology and neuroscience

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access